SciClone Pharmaceuticals (Holdings) Ltd SCCPF:OTCPK

RT Quote | Exchange | USD
Last | EDT
UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High0.00
  • 52 Week High Date-
  • 52 Week Low0.00
  • 52 Week Low Date-

Key Stats

  • Market Cap677.18M
  • Shares Out671.18M
  • 10 Day Average Volume-
  • Dividend0.04
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High0.00
  • 52 Week High Date-
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap677.18M
  • Shares Out671.18M
  • 10 Day Average Volume-
  • Dividend0.04
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.23
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SciClone Pharmaceuticals (Holdings) Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
SciClone Pharmaceuticals Holdings Ltd is a China-based biopharmaceutical company principally engaged in developing and commercializing a portfolio of marketed products as well as pipeline with potential in its focused therapeutic areas including oncology and severe infection. The Company primarily engages in the sales of its proprietary product, Zadaxin, its in-licensed products and promotion products on behalf of its business partners in China.
Zhenfu Li
Non-Executive Chairman of the Board
Hong Zhao
President, Chief Executive Officer, Executive Director
Chihwen Shao
Vice President
Min Jia
Vice President and Head of Immunization Business Department
Lianzong Wu
Vice President
Address
22/F
Central Plaza, 381 Middle Huaihai Road
Shanghai, SHA
China